Dailymotion on MSN
IV therapy surges in popularity despite little evidence of efficacy
In health and wellness circles vitamin IV drips are surging in popularity. There are claims they can boost immunity and slow down aging, but health experts say there's little evidence to back that up.
IV hydration lounges and mobile “drip therapy” services have rapidly expanded across Florida, promising quick recovery from dehydration, fatigue, and illness through vitamin and fluid infusions ...
Halozyme Therapeutics, Inc. (HALO) Presents at The Citizens Life Sciences Conference 2026 Transcript
The Citizens Life Sciences Conference 2026 March 11, 2026 10:45 AM EDTCompany ParticipantsHelen Torley - President, ...
I tried: The "Epic Hangover" IV at Hydrate Medical Dilworth. Think of it as a cocktail for your cells. How it works: Instead ...
"I was fighting to survive": Patients still struggle with preauthorization despite promise of reform
Last summer, the Trump administration announced a voluntary pledge by health insurers to reform prior authorization, but patient advocates and medical providers remain skeptical.
India Today on MSN
Passive euthanasia allowed for Harish Rana: What are the next steps?
Passive euthanasia follows a defined process inside hospitals. After the SC allowed the withdrawal of life-sustaining treatment for Harsh Rana and directed that the patient be admitted to the ...
A Bay Area-based organization that has long offered sexual and reproductive health care is expanding its business model and now offering Botox injections and other new services.
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage biotechnology company developing transformative therapies for the treatment of cancer and rare ...
The incidence of adrenocortical carcinoma is stable over time, but the survival for stage IV disease has improved, with the centralisation of care being associated with better survival.
Initiated higher-dose CBeyond Expansion Study (Part C) to generate higher-exposure human safety and pharmacokinetic data with 400 mg and 600 mg ...
Investigators sought to determine if the gemcitabine intravesical system plus intravenous cetrelimab could improve survival for patients with muscle-invasive bladder cancer who did not receive radical ...
A Main Line Today editor shares what happened when she had a seat and took the leap into IV therapy not once, but twice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results